Neurological complications of hematopoietic cell transplantation

Seminars in Neurology

Volumn 24, Issue 4, 2004, Pages 427-434

  Saiz, Albert ^b   Graus, Francesc ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Encephalitis; Hematopoietic cell transplantation; Immunosuppression; Neurotoxicity; Septic infarction; Subdural hematoma

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; BUSULFAN; CEFEPIME; CYCLOSPORIN; DEXAMETHASONE; IFOSFAMIDE; IMIPENEM; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; TACROLIMUS;

ALLOGENIC BONE MARROW TRANSPLANTATION; AMNESIA; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BACTERIAL INFECTION; BONE MARROW DEPRESSION; BRAIN DISEASE; BRAIN INFARCTION; GRAFT VERSUS HOST REACTION; HALLUCINATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOENCEPHALOPATHY; MYELORADICULOPATHY; MYOCLONUS; NEUROLOGIC DISEASE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PARANEOPLASTIC NEUROPATHY; PARESTHESIA; PRIORITY JOURNAL; REVIEW; SEIZURE; SUBDURAL HEMATOMA; TOXOPLASMOSIS; TREMOR; VIRUS INFECTION;

BRAIN MAPPING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MAGNETIC RESONANCE IMAGING; NERVOUS SYSTEM DISEASES;

EID: 11344260001     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-861537     Document Type: Review

References (64)

1. Armitage JO. Bone marrow transplantation. N Engl J Med 1994;330:827-838
2. Davis DG, Patchell RA. Neurologic complications of bone marrow transplantation. Neurol Clin 1988;6:377-387
3. Openshaw H, Slatkin EN. Neurological complications. In: Thomas ED, Blume KG, Forman SJ, eds. Hematopoietic Cell Transplantation Malden MA: Blackwell Scientific Inc; 1999:659-673
4. Patchell RA. Neurological complications of organ transplantation. Ann Neurol 1994;36:688-703
5. Wiznitzer M, Packer RJ, August CS, Burkey ED. Neurological complications of bone marrow transplantation in childhood. Ann Neurol 1984;16:569-576
6. Patchell RA, White CL, Clark AW, Beschorner WE, Santos GW. Neurological complications of bone marrow transplantation. Neurology 1985;35:300-306
7. Mohrmann RL, Mah V, Vinters HV. Neuropathologic findings after bone marrow transplantation: an autopsy study. Hum Pathol 1990;21:630-639
8. Graus F, Saiz A, Sierra J, et al. Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: A comparative study. Neurology 1996;46:1004-1009
9. Antonini G, Ceschin V, Morino S, et al. Early neurologic complications following allogeneic bone marrow transplant for leukemia. Neurology 1998;50:1441-1445
10. Bleggi-Torres LF, de Medeiros BC, Werner B, et al. Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases. Bone Marrow Transplant 2000;25: 301-307
11. de Brabander C, Cornelissen J, Smitt PA, Vecht CJ, van den Bent MJ. Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donors. J Neurol Neurosurg Psychiatry 2000; 68:36-40
12. Snider S, Bashir R, Bierman P. Neurologic complications after high-dose chemotherapy and autologous bone marrow transplantation for Hodgkin's disease. Neurology 1994;44:681-684
13. Lieberman F, Gulati S. Headaches after inadvertent lumbar puncture during bone marrow harvest. Neurology 1996;46: 268-269
14. Sylvestre DL, Sandson TA, Nachmanoff DB. Transient brachial plexopathy as a complication of internal jugular vein cannulation. Neurology 1991;41:760
15. DiMaggio JR, Brown R, Baile WF, Schapira D. Hallucinations and ifosfamide-induced neurotoxicity. Cancer 1994;73: 1509-1514
16. Posner JB. Side effects of chemotherapy. In: Neurologic Complications of Cancer. Philadelphia: FA Davis Company; 1995:282-310
17. Tahsildar HI, Remler BF, Creger RJ, et al. Delayed, transient encephalopathy after marrow transplantation: case reports and MRI findings in four patients. J Neurooncol 1996;27:241-250
18. Hoyt R, Szer J, Grigg A. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transplant 2000;25: 1285-1287
19. Dixit S, Kurle P, Buyan-Dent L, Sheth RD. Status epilepticus associated with cefepime. Neurology 2000;54:2153-2155
20. Bleggi-Torres LF, Medeiros BC, Ogasawara VSA, et al. Iatrogenic Wernicke's encephalopathy in allogeneic bone marrow transplantation: a study of eight cases. Bone Marrow Transplant 1997;20:391-395
21. Wade JC, Meyers JD. Neurologic symptoms associated with patenteral acyclovir treatment after marrow transplantation. Ann Intern Med 1983;98:921-925
22. Gordon B, Lyden E, Lynch J, et al. Central nervous system dysfunction as the first manifestation of multiple organ dysfunction syndrome in stem cell transplant patients. Bone Marrow Transplant 2000;25:79-83
23. Pomeranz S, Naparstek E, Ashkenazi E, et al. Intracranial hematomas following bone marrow transplantation. J Neurol 1994;241:252-256
24. Colosimo M, McCarthy N, Jayasinghe R, Morton J, Taylor K, Durrant S. Diagnosis and management of subdural hematoma complicating bone marrow transplantation. Bone Marrow Transplant 2000;25:549-552
25. Coplin WM, Cochran MS, Levine SR, Crawford SW. Stroke after bone marrow transplantation. Frequency, aetiology and outcome. Brain 2001;124:1043-1051
26. DeLone DR, Goldstein RA, Petermann G, et al. Disseminated aspergillosis involving the brain: distribution and imaging characteristics. AJNR Am J Neuroradiol 1999;20: 1597-1604
27. Jantunen E, Piilonen A, Volin L, Parkkali T, Koukila-Kahkola P, Ruutu T. Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients. Bone Marrow Transplant 2000;25:867-871
28. Jantunen E, Ruutu P, Piilonen A, Volin L, Parkkali T, Ruutu T. Treatment and outcome of invasive aspergillus infections in allogeneic BMT recipients. Bone Marrow Transplant 2000; 26:759-762
29. Patterson TF, Kirkpatrick WR, White M, et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. Medicine 2000;79:250-260
30. Shah AK. Cyclosporine A neurotoxicity among bone marrow transplant recipients. Clin Neuropharmacol 1999;22:67-73
31. Reece DE, Frei-Lahr DA, Shepherd JD, et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant 1991;8:393-401
32. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500
33. Atkinson K, Biggs J, Darveniza P, Boland J, Concannon A, Dodds A. Cyclosporine-associated central nervous system toxicity after allogeneic bone marrow transplantation. Transplantation 1984;38:34-37
34. Bartynski WS, Zeigler Z, Spearmen MP, Lin L, Shadduck RK, Lister J. Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. AJNR Am J Neuroradiol 2001;22:1901-1914
35. Casey SO, Sampaio RC, Michel E, Truwit CL. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 2000;21:1199-1206
36. Furukawa M, Terae S, Chu BC, Kaneko K, Kamada H, Miyasaka K. MRI in seven cases of tacrolimus (FK-506) encephalopathy: utility of FLAIR and diffusion-weighted imaging. Neuroradiology 2001;43:615-621
37. Steg RE, Garcia EG. Complex visual hallucinations and cyclosporine neurotoxicity. Neurology 1991;41:1156
38. Balmaceda CM, Walker RW, Castro-Malaspina H, Dalmau J. Reversal of amphotericin-B-related encephalopathy. Neurology 994;44:1183-1184
39. Miyao S, Takano A, Teramoto J, Fujitake S, Hashizume Y. Oculomotor nerve palsy due to intraneural hemorrhage in idiopathic thrombocytopenic purpura: a case report. Eur Neurol 1993;33:20-22
40. Edelson RN, Chernik NL, Posner JB. Spinal subdural hematomas complicating lumbar puncture. Arch Neurol 1974;31: 134-137
41. Wen PY, Alyea EP, Simon D, Herbst RS, Soiffer RJ, Antin JH. Guillain-Barré syndrome following allogeneic bone marrow transplantation. Neurology 1997;49:1711-1714
42. Martino R, Bretagne S, Rovira M, et al. Toxoplasmosis after hematopoietic stem transplantation. Report of a 5-year survey from the Infectious Disease Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2000;25:1111-1113
43. Chandrasekar PH, Momin F,and the Bone Marrow Transplant Team. Disseminated toxoplasmosis in marrow transplant recipients: a report of three cases and review of the literature. Bone Marrow Transplant 1997;19:685-689
44. Maschke M, Dietrich U, Prumbaum M, et al. Opportunistic CNS infections after bone marrow transplantation. Bone Marrow Transplant 1999;23:1167-1176
45. Davis D, Henslee PJ, Markesbery WR. Fatal adenovirus meningoencephalitis in a bone marrow transplant patient. Ann Neurol 1988;23:385-389
46. Conti DJ, Rubin RH. Infection of the central nervous system in organ transplant recipients. Neurol Clin 1988;6:241-260
47. Cordonnier C, Feuilhade F, Vernant JP, Marsault C, Rodet M, Rochant H. Cytomegalovirus encephalitis occurring after bone marrow transplantation. Scand J Haematol 1983;31: 248-252
48. Koc Y, Miller KB, Schenkein DP, et al. Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome. Biol Blood Marrow Transplant 2000;6:44-49
49. Mookerjee BP, Vogelsang G. Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir. Bone Marrow Transplant 1997; 20:905-906
50. Wainwright MS, Martin PL, Morse RP, et al. Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol 2001;50:612-619
51. Guppy KH, Thomas C, Thomas K, Anderson D. Cerebral fungal infections in the immunocompromised host: a literature review and a new pathogen - Chaetomium atrobrunneum: case report. Neurosurgery 1998;43:1463-1469
52. Hagensee ME, Bauwens JE, Kjos B, Bowden RA. Brain abscess following marrow transplantation: Experience at the Fred Hutchinson Cancer Research Center, 1984-1992. Clin Infect Dis 1994;19:402-408
53. Coppo P, Laporte JPh, Aoudjhane M, et al. Progressive multifocal leucoencephalopathy with peripheral demyelinating neuropathy after autologous bone marrow transplantation for acute myeloblastic leukemia (FAB5). Bone Marrow Transplant 1999;23:401-403
54. Re D, Bamborschke S, Feiden W, et al. Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation and alpha-interferon immunotherapy. Bone Marrow Transplant 1999;23:295-298
55. Reyes MG, Noronha P, Thomas W, Heredia R. Myositis of chronic graft versus host disease. Neurology 1983;33:1222-1224
56. Grau JM, Casademont J, Monforte R, et al. Myasthenia gravis after allogeneic bone marrow transplantation: report of a new case and pathogenetic considerations. Bone Marrow Transplant 1990;5:435-437
57. Amato AA, Barohn RJ, Sahenk Z, Tutschka PJ, Mendell JR. Polyneuropathy complicating bone marrow and solid organ transplantation. Neurology 1993;43:1513-1518
58. Iwasaki Y, Sako K, Ohara Y, et al. Subacute panencephalitis associated with chronic graft-versus-host disease. Acta Neuropathol (Berl) 1993;85:566-572
59. Padovan CS, Bise K, Hahn J, et al. Angiitis of the central nervous system after allogeneic bone marrow transplantation. Stroke 1999;30:1651-1656
60. Padovan CS, Yousry TA, Schleuning M, Holler E, Kolb HJ, Straube A. Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation. Ann Neurol 1998;43:627-633
61. Ma M, Barnes G, Pulliam J, Jezek D, Baumann RJ, Berger JR. CNS angiitis in graft vs host disease. Neurology 2002;59: 1994-1997
62. Sostak P, Padovan CS, Yousry TA, Ledderose G, Kolb HJ, Straube A. Prospective evaluation of neurological complications after allogenic bone marrow transplantation. Neurology 2003;60:842-848
63. Cohen JI. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine 1991; 70:137-160
64. Curtis RE, Rowlings PA, Deeg J, et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997;336:897-904